Role of radiation therapy in the treatment of melanoma

Steven E. Schild

Research output: Contribution to journalArticle

Abstract

Melanoma has been widely described as radioresistant but this should not be construed as meaning that melanoma is radioincurable. Many melanoma cell lines are as radiosensitive as other tumors commonly treated successfully with radiotherapy (RT). The use of RT requires careful planning resulting in the administration of a tumoricidal dose to the tumor cells with adequate sparing of normal tissues. RT has been used for primary therapy, postresection adjuvant therapy and palliation of symptomatic melanoma. Curative RT has been given for uveal melanoma yielding patient survival equivalent to enucleation. RT has been administered to patients with unresectable disease yielding relatively favorable results. As an adjuvant therapy postoperatively, RT has been used selectively to improve local disease control. Finally, RT is used successfully as a palliative maneuver for symptoms related to distant metastatic melanoma in patients with incurable disease.

Original languageEnglish (US)
Pages (from-to)583-586
Number of pages4
JournalExpert Review of Anticancer Therapy
Volume9
Issue number5
DOIs
StatePublished - 2009

Fingerprint

Melanoma
Radiotherapy
Therapeutics
Neoplasms
Cell Line
Survival

Keywords

  • Adjuvant therapy
  • Melanoma
  • Metastases
  • Palliative therapy
  • Primary therapy
  • Radiation therapy

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Role of radiation therapy in the treatment of melanoma. / Schild, Steven E.

In: Expert Review of Anticancer Therapy, Vol. 9, No. 5, 2009, p. 583-586.

Research output: Contribution to journalArticle

Schild, Steven E. / Role of radiation therapy in the treatment of melanoma. In: Expert Review of Anticancer Therapy. 2009 ; Vol. 9, No. 5. pp. 583-586.
@article{b11fbffab9674be3958ae886a5be2319,
title = "Role of radiation therapy in the treatment of melanoma",
abstract = "Melanoma has been widely described as radioresistant but this should not be construed as meaning that melanoma is radioincurable. Many melanoma cell lines are as radiosensitive as other tumors commonly treated successfully with radiotherapy (RT). The use of RT requires careful planning resulting in the administration of a tumoricidal dose to the tumor cells with adequate sparing of normal tissues. RT has been used for primary therapy, postresection adjuvant therapy and palliation of symptomatic melanoma. Curative RT has been given for uveal melanoma yielding patient survival equivalent to enucleation. RT has been administered to patients with unresectable disease yielding relatively favorable results. As an adjuvant therapy postoperatively, RT has been used selectively to improve local disease control. Finally, RT is used successfully as a palliative maneuver for symptoms related to distant metastatic melanoma in patients with incurable disease.",
keywords = "Adjuvant therapy, Melanoma, Metastases, Palliative therapy, Primary therapy, Radiation therapy",
author = "Schild, {Steven E.}",
year = "2009",
doi = "10.1586/ERA.09.21",
language = "English (US)",
volume = "9",
pages = "583--586",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Role of radiation therapy in the treatment of melanoma

AU - Schild, Steven E.

PY - 2009

Y1 - 2009

N2 - Melanoma has been widely described as radioresistant but this should not be construed as meaning that melanoma is radioincurable. Many melanoma cell lines are as radiosensitive as other tumors commonly treated successfully with radiotherapy (RT). The use of RT requires careful planning resulting in the administration of a tumoricidal dose to the tumor cells with adequate sparing of normal tissues. RT has been used for primary therapy, postresection adjuvant therapy and palliation of symptomatic melanoma. Curative RT has been given for uveal melanoma yielding patient survival equivalent to enucleation. RT has been administered to patients with unresectable disease yielding relatively favorable results. As an adjuvant therapy postoperatively, RT has been used selectively to improve local disease control. Finally, RT is used successfully as a palliative maneuver for symptoms related to distant metastatic melanoma in patients with incurable disease.

AB - Melanoma has been widely described as radioresistant but this should not be construed as meaning that melanoma is radioincurable. Many melanoma cell lines are as radiosensitive as other tumors commonly treated successfully with radiotherapy (RT). The use of RT requires careful planning resulting in the administration of a tumoricidal dose to the tumor cells with adequate sparing of normal tissues. RT has been used for primary therapy, postresection adjuvant therapy and palliation of symptomatic melanoma. Curative RT has been given for uveal melanoma yielding patient survival equivalent to enucleation. RT has been administered to patients with unresectable disease yielding relatively favorable results. As an adjuvant therapy postoperatively, RT has been used selectively to improve local disease control. Finally, RT is used successfully as a palliative maneuver for symptoms related to distant metastatic melanoma in patients with incurable disease.

KW - Adjuvant therapy

KW - Melanoma

KW - Metastases

KW - Palliative therapy

KW - Primary therapy

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=68149160028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68149160028&partnerID=8YFLogxK

U2 - 10.1586/ERA.09.21

DO - 10.1586/ERA.09.21

M3 - Article

C2 - 19445575

VL - 9

SP - 583

EP - 586

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 5

ER -